Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naveed H Akhtar

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Journal of Urology|November 16, 2010
Editorial commentNaveed H Akhtar, Scott T Tagawa
Prostate Cancer|May 24, 2012
The current role of androgen deprivation in patients undergoing dose-escalated external beam radiation therapy for clinically localized prostate cancerMichael J Smith, Naveed H Akhtar, Scott T Tagawa
Advances in Urology|August 4, 2011
Prostate-specific membrane antigen-based therapeuticsNaveed H Akhtar, Orrin Pail, Ankeeta Saran, et al.
Expert Opinion on Therapeutic Patents|April 16, 2013
PSMA-targeted dendrimers: a patent evaluation (WO2012078534)Naveed H Akhtar, Joseph R Osborne, Shoaib B Fareedy, et al.
Advances in Urology|June 14, 2012
Review of salvage therapy for biochemically recurrent prostate cancer: the role of imaging and rationale for systemic salvage targeted anti-prostate-specific membrane antigen radioimmunotherapySatyajit Kosuri, Naveed H Akhtar, Michael Smith, et al.
Urologic Oncology|June 5, 2012
Prostate-specific membrane antigen-based imagingJoseph R Osborne, Naveed H Akhtar, Shankar Vallabhajosula, et al.
Frontiers in Oncology|October 23, 2012
Isolation and characterization of circulating tumor cells in prostate cancerElan Diamond, Guang Yu Lee, Naveed H Akhtar, et al.
Frontiers in Oncology|August 30, 2013
Bone marrow recovery and subsequent chemotherapy following radiolabeled anti-prostate-specific membrane antigen monoclonal antibody j591 in men with metastatic castration-resistant prostate cancerScott T Tagawa, Naveed H Akhtar, Anastasia Nikolopoulou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 30, 2013
Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancerScott T Tagawa, Matthew I Milowsky, Michael Morris, et al.
Plos One|January 4, 2014
Circulating tumor cells from prostate cancer patients interact with E-selectin under physiologic blood flowGunjan Gakhar, Vicente N Navarro, Madelyn Jurish, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of Urology|November 16, 2010
Editorial commentNaveed H Akhtar, Scott T Tagawa
Prostate Cancer|May 24, 2012
The current role of androgen deprivation in patients undergoing dose-escalated external beam radiation therapy for clinically localized prostate cancerMichael J Smith, Naveed H Akhtar, Scott T Tagawa
Advances in Urology|August 4, 2011
Prostate-specific membrane antigen-based therapeuticsNaveed H Akhtar, Orrin Pail, Ankeeta Saran, et al.
Expert Opinion on Therapeutic Patents|April 16, 2013
PSMA-targeted dendrimers: a patent evaluation (WO2012078534)Naveed H Akhtar, Joseph R Osborne, Shoaib B Fareedy, et al.
Advances in Urology|June 14, 2012
Review of salvage therapy for biochemically recurrent prostate cancer: the role of imaging and rationale for systemic salvage targeted anti-prostate-specific membrane antigen radioimmunotherapySatyajit Kosuri, Naveed H Akhtar, Michael Smith, et al.
Urologic Oncology|June 5, 2012
Prostate-specific membrane antigen-based imagingJoseph R Osborne, Naveed H Akhtar, Shankar Vallabhajosula, et al.
Frontiers in Oncology|October 23, 2012
Isolation and characterization of circulating tumor cells in prostate cancerElan Diamond, Guang Yu Lee, Naveed H Akhtar, et al.
Frontiers in Oncology|August 30, 2013
Bone marrow recovery and subsequent chemotherapy following radiolabeled anti-prostate-specific membrane antigen monoclonal antibody j591 in men with metastatic castration-resistant prostate cancerScott T Tagawa, Naveed H Akhtar, Anastasia Nikolopoulou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 30, 2013
Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancerScott T Tagawa, Matthew I Milowsky, Michael Morris, et al.
Plos One|January 4, 2014
Circulating tumor cells from prostate cancer patients interact with E-selectin under physiologic blood flowGunjan Gakhar, Vicente N Navarro, Madelyn Jurish, et al.
Pageof 1